Company Overview and News

BBY / Best Buy Co., Inc. 8-K (Current Report)

Upvote Downvote

Roku's Long-Term Potential Is Unaffected By Amazon And Best Buy

2018-04-20 seekingalpha
TV is a commoditized business, it's not surprising to me that Insignia wants to differentiate. TCL is currently the dominant Roku TV brand.
Upvote Downvote

Best Buy Co Inc and, Inc. Partner on TV Sales

2018-04-19 investorplace, Inc. (NASDAQ:AMZN) and Best Buy Co Inc (NYSE:BBY) are fierce competitors. However, the two rivals just announced a historic partnership designed to leverage “showrooming” to their mutual benefit. Best Buy will begin carrying a new Amazon Fire Edition TV lineup in its stores, with Amazon Fire and Alexa integration. In addition, Best Buy will sell the smart TVs on, as a third-party seller.
Upvote Downvote

Don’t Write Off Bed Bath & Beyond Inc. Stock Just Yet

2018-04-13 investorplace
Bed Bath & Beyond Inc. (NASDAQ:BBBY) fell hard following an earnings miss. Declining profits have long plagued BBBY stock. Now with the massive drop and more intense competition, investors appear more worried than ever. However, one should also remember that brick-and-mortar-retail still shows signs of strength. Many traditional retailers have found ways to thrive as a result. At BBBY’s low valuation, now could be the time for a speculative position in Bed Bath & Beyond stock.
Upvote Downvote

Bespoke's Most Volatile Stocks On Earnings: April 2018 Edition

2018-04-10 seekingalpha
The first-quarter earnings season began Monday. With the stock market struggling lately, there seem to be a lot of bulls hanging their hopes on earnings strength to help pull the market out of correction territory.
Upvote Downvote

Target Corporation Has Enjoyed Its Run But Now It’s Time to Walk Away | InvestorPlace

2018-04-09 investorplace
Since announcing their controversial restroom policy in 2016, Target Corporation (NYSE:TGT) has mostly been a hot mess. Although TGT stock ended that year in the positive (barely at just under 4%), the first half of 2017 was a disaster.
Upvote Downvote

Best Buy Buries Comments on Cyberattack

2018-04-07 247wallst
Best Buy Co. Inc. (NYSE: BBY) was hit by a cyberattack. Try to find the announcement at the Best Buy website. It is not on the home page, where it would be most visible. It is in a blog post, where few Best Buy customers can or will find it.
Upvote Downvote

Customer Data for Delta, Sears, Best Buy, Others May Have Been Stolen

2018-04-06 247wallst
A malware attack against a company that provides contract chat services to some of America’s best-known companies could have resulted in the leak of hundreds of thousands of customers’ personal information. The data would have been leaked last fall between September 26 and October 12, according to statements from three companies.
Upvote Downvote

BBY / Best Buy Co., Inc. 10-K (Annual Report)

Upvote Downvote

Roku's Business Is Not What You Think

2018-04-01 seekingalpha
Its digital ad platform is addressing an enormous transitioning market worth over $150 billion just in the U.S.
Upvote Downvote

NueroMetrix, Inc.: An Interesting Micro-Cap Flyer?

2018-03-31 seekingalpha
On January 17, 2018, NueroMetrix announced a strategic partnership with GlaxoSmithKline plc. GSK paid NURO $5 million upfront and signed a partnership with up to $21.5 million in milestones.
Upvote Downvote

Growth At GameStop Falters

2018-03-28 seekingalpha
Growth rate of collectables is decelerating, and that's a worry as the other growth drivers are faring even worse.
Upvote Downvote

Best Buy: On Track To Surpass $5 Billion In Domestic Online Sales This Year

2018-03-27 seekingalpha
Revenues have been down the last few years. However, it has been able to increase its net income.
Upvote Downvote

BBY / Best Buy Co., Inc. 8-K (Current Report)

Upvote Downvote

6 Most Important Things In Business Today

2018-03-22 247wallst
Facebook (NASDAQ: FB) CEO Mark Zuckerberg said the company would do more to protect user data. A story by 24/7 Wall St. covered the news.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 086516101